The history of multiple sclerosis (MS) is dominated by the discoveries of famous men. However, women would like to feel part of the story and to know that women have contributed to MS research.
Objective:
To identify women who contributed to the history of discovery in MS.
Method:
This was a personal survey from my knowledge of previous work.
Results:
There were no women participants in the early stages of MS research. However, since 1950 there are many women who have contributed to MS research. In the 20th century, there were famous women who contributed to the scientific fields that form the basis of MS research. In the 21st century, more women participate in MS research but studies suggest that they are under-represented in positions of prominence.
Conclusion:
Women have been part of the effort to understand MS, but are not well recognized.
FlemmingR.Women, writing and medicine in the classical world. Classical Quart2007; 57: 257–279.
2.
GreenM.Women’s medical practice and health care in medieval Europe. Signs1989; 14(2): 434–474.
3.
YoungsonAJ.Medical education in the later 19th century: The science take-over. Med Educ1989; 23(6): 480–491.
4.
WilkinsonMIslerH.The pioneer woman’s view of migraine: Elizabeth Garrett Anderson’s thesis ‘Sur la migraine’. Cephalalgia1999; 19(1): 3–15.
5.
BerhouneNNThoboisSGobertF, et al. Augusta Dejerine-Klumpke (1859–1927): An extraordinary neurologist and an inspiration for all women in medical careers. Pediatr Neurol2014; 50(6): 547–548.
6.
ShojaMMTubbsRS.Augusta Dejerine-Klumpke: The first female neuroanatomist. Clin Anat2007; 20(6): 585–587.
7.
KoehlerPJ.Gabrielle Levy and the Roussy-Levy syndrome. J Hist Neurosci2018; 27(2): 117–144.
8.
PearceJM.Mary Broadfoot Walker (1888–1974): A historic discovery in myasthenia gravis. Eur Neurol2005; 53(1): 51–53.
9.
JohnstonJD. The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London. J Hist Neurosci2005; 14(2): 121–137.
10.
MillerSJGooddyW.Madame Louis-Bar’s Syndrome; a case record, with comments upon the name, classification and significance of this disorder. Brain1964; 87: 581–588.
11.
AllenIV.The pathology of multiple sclerosis—fact, fiction and hypothesis. Neuropathol Appl Neurobiol1981; 7(3): 169–182.
12.
AllenISSaidaT.Editorial. Mult Scler J1995; 1: 1.
13.
AllenIVMcKeownSR.A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci1979; 41(1): 81–91.
14.
BrosnanCFRaineCS.Mechanisms of immune injury in multiple sclerosis. Brain Pathol1996; 6: 243–257.
15.
BrosnanCFSelmajKRaineCS.Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol1988; 18(1): 87–94.
16.
ClaudioLRaineCSBrosnanCF.Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol1995; 90(3): 228–238.
17.
OffnerHAmmitzbollTClausenJ, et al. Immune response of lymphocytes from patients with multiple sclerosis to phytohemagglutinin, basic protein of myelin and measles antigens. Acta Neurol Scand1974; 50(3): 373–381.
18.
VandenbarkAAGillTOffnerH.A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis. J Immunol1985; 135(1): 223–228.
19.
GriffinJFWraySH.Acquired color vision defects in retrobulbar neuritis. Am J Ophthalmol1978; 86(2): 193–201.
20.
ArnasonBGFullerTCLehrichJR, et al. Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J Neurol Sci1974; 22(4): 419–428.
21.
WraySH.The treatment of optic neuritis. Sight Saving Rev1972; 42: 5–13.
22.
SchollGBSongHSWraySH.Uhthoff’s symptom in optic neuritis: Relationship to magnetic resonance imaging and development of multiple sclerosis. Ann Neurol1991; 30(2): 180–184.
23.
ElianMDeanG.Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies. J Neurol Neurosur Ps1987; 50: 327–332.
24.
SadovnickAD.Genetics of multiple sclerosis in British Columbia and throughout Canada. Ann Neurol1994; 36(Suppl.): S18–S21.
25.
Sandberg-WollheimM.Immunoglobulin synthesis in vitro by cerebrospinal fluid cells in patients with multiple sclerosis. Scand J Immunol1974; 3(6): 717–730.
26.
Sandberg-WollheimM.Optic neuritis: Studies on the cerebrospinal fluid in relation to clinical course in 61 patients. Acta Neurol Scand1975; 52(3): 167–178.
27.
CoylePK.Detection and isolation of immune complexes in multiple sclerosis cerebrospinal fluid. J Neuroimmunol1987; 15(1): 97–107.
28.
CoylePK.The neuroimmunology of multiple sclerosis. Adv Neuroimmunol1996; 6: 143–154.
29.
Levi-MontalciniRKnightRANicoteraP, et al. Rita’s 102!!Mol Neurobiol2011; 43: 77–79.
30.
GreerJMLeesMB.Myelin proteolipid protein – the first 50 years. Int J Biochem Cell Biol2002; 34(3): 211–215.
KitleyJWoodhallMWatersP, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology2012; 79(12): 1273–1277.
40.
ThomsonAHHorneRChungC, et al. Visibility and representation of women in multiple sclerosis research. Neurology2019; 92(15): 713–719.
41.
ShannonGJansenMWilliamsK, et al. Gender equality in science, medicine, and global health: Where are we at and why does it matter. Lancet2019; 393(10171): 560–569.
42.
International Women in MS. Gender inequities in the multiple sclerosis community: A call for action. Ann Neurol2018; 84: 958–959.
43.
ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17: 162–173.
44.
MoneimJColesAGiovannoniG, et al. Women on multiple sclerosis clinical trial steering committees. Ann Neurol2018; 84(2): 329–330.
